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Abstract Pulsed field gel electrophoresis showed that the
initiation time of DNA breakage induced by the DNA alkylating
agent duocarmycin A, which is not a redox-cycling agent, was
almost the same in the human leukemia cell line HL-60 and its
H2O2-resistant clone HP100. Catalase activity of HP100 cells
was much higher than that of HL-60 cells. Duocarmycin A-
mediated DNA ladder formation in HP100 cells was delayed
compared with that in HL-60 cells, suggesting the involvement of
H2O2 in duocarmycin A-induced apoptosis. Flow cytometry
demonstrated that peroxide formation preceded loss of mito-
chondrial membrane potential (v8m) in cells treated with
duocarmycin A. Then, caspase-3 was activated, followed by
DNA ladder formation. These findings suggest that DNA
damage by duocarmycin A induces H2O2 generation, which
causes v8m loss and subsequently caspase-3 activation, resulting
in apoptosis.
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1. Introduction
Reactive oxygen species (ROS) such as O32 and H2O2 are
important regulators of apoptosis [1^3]. H2O2 can induce
apoptosis [4] and antioxidants such as N-acetylcysteine [5],
thioredoxin [6] and MnSOD [7] can delay or inhibit apoptosis.
Other apoptotic stimuli, such as tumor necrosis factor K [8],
ceramide [9] and lipopolysaccharide [10], result in generation
of intracellular H2O2 during the apoptotic pathway.
It is well known that anticancer drugs, which cause DNA
damage, can induce apoptosis [11^13]. Recent reports have
suggested that DNA damage results in perturbation of inner
mitochondrial membrane permeability [14^16]. Mitochondrial
permeability transition (MPT), which involves a sudden in-
crease of the mitochondrial membrane permeability, is a cen-
tral coordination event of apoptosis [17^19]. It has been
postulated that MPT could be caused by exogenous and en-
dogenous ROS [17]. Although mitochondria are usually the
main source of ROS in the cells, there remains the possibility
that redox enzymes other than mitochondrial respiratory
chain are sources of ROS. Here, we addressed the question
of whether ROS generated from other systems than mitochon-
dria activate MPT in the DNA damage-induced apoptotic
pathway.
In this study, we investigated the causal relationship be-
tween DNA damage, generation of H2O2, and decrease in
mitochondrial membrane potential (v8m) during apoptosis.
The v8m disruption is mediated by opening MPT pores and
appears to be critical for the apoptotic cascade [17]. We used
duocarmycin A, an anticancer drug which induces DNA dam-
age without H2O2 generation in a cell-free system, because
duocarmycin A has highly speci¢c DNA recognition and no
redox-cycling activity [20,21]. That is, duocarmycin A alky-
lates speci¢cally the adenine at AcT-rich sequences in double-
stranded DNA [22] and induces cellular DNA damage [23].
HP100, which is a H2O2-resistant cell line derived from HL-
60, was used to assess whether H2O2 participates in duocar-
mycin A-induced apoptosis. The catalase activity of HP100
cells was much higher than that of HL-60 cells [24]. In addi-
tion, since it is known that MPT initiates the activation of
caspases [17,25,26], the time course of activation of caspase-1
(ICE) and caspase-3 (CPP32) was also investigated.
2. Materials and methods
2.1. Materials
Duocarmycin A was obtained from Kyowa Hakko Kogyo Co.,
Ltd. (Tokyo, Japan). Proteinase K was from Merck (Darmstadt,
Germany). z-Tyr-Val-Ala-Asp-7-amino-4-tri£uoromethyl coumarin
(YVAD-AFC) was from Enzyme System Products (Livermore, CA,
USA). z-Asp-Glu-Val-Asp-7-amino-4-tri£uoromethyl coumarin
(DEVD-AFC) was from Biomol (Plymouth Meeting, PA, USA).
2P,7P-Dichloro£uorescein diacetate (DCFH-DA) and 3,3P-dihexyloxa-
carbocyanine iodide [DiOC6(3)] were from Molecular Probes, Inc.
2.2. Cell culture and treatment with duocarmycin A
HP100 cells have been derived from HL-60 cells by repeated expo-
sure to H2O2, followed by outgrowth of viable cells, and were ap-
proximately 340-fold more resistant to H2O2 than the parent cells,
HL-60 [24]. Catalase activity of HP100 cells is 18 times higher than
that of HL-60 cells. The HL-60 and HP100 cells were grown in RPMI
1640 supplemented with 6% FCS at 37‡C under 5% CO2 in a humidi-
¢ed atmosphere. Cells (106 cells/ml) were treated with 10 nM duocar-
mycin A throughout this experiment.
2.3. Detection of cellular DNA damage and DNA ladder formation
induced by duocarmycin A
After treatment with duocarmycin A, the cells were washed with
PBS. The cell suspension was solidi¢ed with agarose, followed by
treatment with proteinase K according to the method as described
previously [27]. Electrophoresis was performed by a CHEF-DRII
pulsed ¢eld electrophoresis system (Bio-Rad) at 200 V at 14‡C. Switch
time was 60 s for 15 h followed by 90 s for 9 h. DNA ladder for-
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mation, which is characteristic for apoptosis, was analyzed by conven-
tional electrophoresis [28].
2.4. Flow cytometric detection of peroxide and v8m
To evaluate cellular peroxide level, duocarmycin A-treated cells
were incubated with 5 WM DCFH-DA for 30 min at 37‡C [29]. To
assess the change in v8m, duocarmycin A-treated cells were incu-
bated with 40 nM DiOC6(3) for 15 min at 37‡C [30]. Then, the cells
were washed with PBS twice and suspended in PBS and then were
analyzed with a £ow cytometer (FACScan, Becton Dickinson). Dead
cells and debris were excluded from the analysis by electronic gating
of forward and side scatter measurements.
2.5. Measurement of activities of caspase-1 and caspase-3
For analysis of activities of caspase-1 and caspase-3, the duocarmy-
cin A-treated cells (106 cells) were washed with PBS twice and sus-
pended in 100 Wl of bu¡er A [0.1 M HEPES (pH 7.4), 2 mM DTT,
0.1% CHAPS, 1% sucrose]. The cell lysate was centrifuged at
18 500Ug for 15 min, and the supernatant was obtained. The reaction
was initiated by addition of 20 WM YVAD-AFC or DEVD-AFC to
50 Wl of apoptotic extract at 37‡C and product formation was meas-
ured using a Hitachi F-2000 spectro£uorometer with excitation at 400
nm and emission at 505 nm.
3. Results
3.1. DNA damage and DNA ladder formation in HL-60 and
HP100 cells treated with duocarmycin A
We have analyzed DNA strand breaks in the cells treated
with duocarmycin A using pulsed ¢eld gel electrophoresis.
DNA fragments corresponding to 1^2 Mb appeared not
only in HL-60 cells but also in HP100 cells treated with duo-
carmycin A for 30 min (Fig. 1A), and then, 1^2-Mb frag-
ments disappeared in HL-60 cells at 4 h, suggesting that the
fragments were digested into internucleosomal DNA frag-
ments.
In contrast, DNA ladder formation, which is characteristic
for apoptosis, was already detectable at 2 h in HL-60 cells,
but in the case of HP100 cells it was observed slightly at 3 h
and apparently at 4 h (Fig. 1B). These time course data in-
dicate that apoptosis mediated by DNA damage is delayed in
HP100 cells, suggesting involvement of H2O2 in duocarmycin
A-mediated apoptosis.
3.2. Generation of peroxide and change of v8m in HL-60 and
HP100 cells treated with duocarmycin A
To investigate whether generation of H2O2 precedes or fol-
lows the loss of v8m, peroxide and v8m in both HL-60 and
HP100 cells treated with duocarmycin A were measured. As
shown in Fig. 2, in HL-60 cells, peroxide generation was al-
ready observed at 30 min after treatment with duocarmycin
A, whereas v8m was drastically decreased at 2 h. On the
other hand, in HP100 cells, peroxide generation occurred at
2 h, whereas v8m was not altered at 2 h and apparently
decreased at 3 h (Fig. 2). These results indicate that in HL-
60 cells as well as in HP100 cells, duocarmycin A induces
peroxide production followed by the loss of v8m, although
there is an about 1^1.5-h delay between the increase of per-
oxide level in HL-60 cells and that in HP100 cells.
3.3. Activation of caspase-3 by duocarmycin A
It has been well documented that caspase-1 and its related
cysteine proteases such as caspase-3 play important roles in
apoptosis [31^34]. Activation of caspase-1 and caspase-3 in
duocarmycin A-treated cells was measured using a £uoromet-
ric assay with the substrates YVAD-AFC and DEVD-AFC,
respectively. In HL-60 cells, maximal caspase-3 activity was
observed after treatment with duocarmycin A for 3 h (Fig. 3).
In contrast, in HP100 cells, maximal caspase-3 activity was
observed at 4 h after treatment with duocarmycin A (Fig. 3).
There was a delay of about 1 h between the 50% of caspase-3
activity in HL-60 cells and that in HP100 cells. Caspase-1 was
not activated by treatment with duocarmycin A in HL-60 cells
(Fig. 3) and HP100 cells (data not shown). These results in-
dicate that caspase-3 is involved in duocarmycin A-induced
apoptosis and that DNA ladder formation follows the activa-
tion of caspase-3.
4. Discussion
The present study demonstrated that duocarmycin A in-
duced DNA strand breakage in HL-60 and H2O2-resistant
HP100 cells at the same time. However, subsequent events
in the apoptotic pathway of HP100 cells were delayed com-
pared with that of HL-60 cells. The catalase activity of HP100
cells was 18 times higher than that of HL-60 cells [24]. There-
fore, it is considered that generation of H2O2 plays a critical
role in duocarmycin A-mediated apoptosis but not in duocar-
mycin A-induced DNA damage.
Recent reports suggest that DNA damage results in onset
of MPT, which plays a major role in the apoptotic process
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Fig. 1. Detection of cellular DNA damage and DNA ladder forma-
tion in HL-60 and HP100 cells treated with duocarmycin A. HL-60
and HP100 cells (1U106 cells/ml) were treated with 10 nM duocar-
mycin A at 37‡C for the indicated times. A: Cells were prepared as
agarose plugs, lysed and subjected to pulsed ¢eld gel electrophoresis
through a 1% agarose gel, as described in Section 2. The gel was
stained in ethidium bromide. Marker lane: size maker DNA (Sac-
charomyces cerevisiae). B: The cells were lysed, and DNA was ex-
tracted and analyzed by conventional electrophoresis as described in
Section 2. Marker lane: size marker DNA (xX174/HaeIII digest).
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[14^16]. A common step in apoptosis involves the loss of v8m
resulting in increased generation of ROS from the mitochon-
drial respiratory chain [17,25]. However, the mechanisms in-
volved in the loss of v8m caused by DNA damage remain to
be clari¢ed. The present study has shown that in HL-60 cells,
the level of peroxide began to increase at 30 min after the
treatment with duocarmycin A, and v8m was decreased at
about 1.5 h. In contrast, in HP100 cells, the level of peroxide
began to increase at 1 h, and v8m began to decrease at 2 h.
Although DCFH-DA is used for detecting peroxide, it is con-
sidered on the basis of the comparison of HL-60 and HP100
cells that the peroxide detected in this experiment is mostly
H2O2. These data are the ¢rst to demonstrate that H2O2 for-
mation precedes the loss of v8m in the DNA damage-induced
apoptotic process. DNA damage and H2O2 production were
likely to be parallel events triggered by duocarmycin A. How-
ever, since duocarmycin A is not a redox-cycling agent,
we reasonably consider a possibility that H2O2 is produced
by DNA damage induced by duocarmycin A. The resultant
intracellular H2O2 produced by DNA damage might attack
mitochondrial membranes. This idea is supported by a
recent paper suggesting that O32 production activates MPT
[2].
Here, the question has been raised how DNA damage in-
duces O32 and subsequent H2O2 generation before the onset of
MPT. There are several papers suggesting that mitochondria
are the main source of ROS and that MPT contributes the
generation of O32 and subsequent H2O2 generation [2,25,35].
However, mechanisms underlying ROS generation in other
systems than mitochondria remain unclear. A recent study
demonstrated rapid and speci¢c H2O2 generation via
NADH oxidase activation during Fas-mediated apoptosis
[36]. In addition, Polyak et al. reported that p53, which can
be induced by DNA damage, may result in apoptosis through
the transcriptional induction of redox-related genes and the
formation of ROS [37,38]. This possibility would be excluded
in the present study since HL-60 is a p53-null cell line [39].
Alternatively, a mechanism for the DNA damage-induced
ROS may be explained on the basis of the observation that
DNA strand breakage can lead to activation of poly(ADP-
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Fig. 2. Generation of H2O2 and the loss of v8m in HL-60 and HP100 cells treated with duocarmycin A. HL-60 and HP100 cells (1U106 cells/
ml) were treated with 10 nM duocarmycin A at 37‡C for the indicated times. After the treatment, the cells were incubated with 5 WM DCFH-
DA for 30 min at 37‡C (A) or 40 nM DiOC6(3) for 15 min at 37‡C (B). The cells were analyzed with a £ow cytometer (FACScan). The hori-
zontal axis shows the relative £uorescence intensity, and the vertical axis shows the cell number. Dotted curves at 0.5^3 h correspond to control
cells, like the solid curves at 0 h. Solid curves at 0.5^3 h represent duocarmycin A-treated cells.
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ribose) polymerase (PARP) with resulting loss of NAD and
ATP, which decreases the GSH/GSSG ratio [40,41]. Recent
studies suggest that a depletion of GSH regulates MPT
[42,43]. Therefore, it is reasonably considered that the intra-
cellular GSH decrease via DNA damage results in an accu-
mulation of excessive amounts of ROS and subsequently
MPT may be activated, followed by cell death. Although an
early increase in ROS is coupled to GSH depletion, a later
increase in ROS may be additionally derived from the mito-
chondrial respiratory chain through the MPT pore a¡ected by
an early increase in ROS [1,14,19].
Previous studies have shown that cytochrome c, which is
released from mitochondria during the induction of apoptosis,
can initiate cleavage of pro-caspase-3 and activation of cas-
pase-3 [26]. The present study suggests that the caspase-3 ac-
tivation induced by duocarmycin A increases immediately
after the loss of v8m. This led us to an idea that during
duocarmycin A-induced apoptosis the loss of v8m results in
the activation of caspase-3. It was also reported that the acti-
vated caspase-3 cleaved DNA fragmentation factor, which is a
human homologue of the mouse inhibitor of caspase-activated
deoxyribonuclease [44,45], and led to DNA fragmentation at
internucleosomal sites. Thus, it is concluded that DNA dam-
age induces the generation of H2O2 which causes MPT, and
subsequently initiates the activation of caspase-3, resulting in
apoptosis.
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Fig. 3. Activation of caspase-1 and -3 in duocarmycin A-treated
cells. Caspase-1 and -3 activities were measured by cleavage of
YVAD- and DEVD-AFC respectively, using extracts of HL-60 and
HP100 cells undergoing duocarmycin A-induced apoptosis. The cells
(1U106 cells/ml) were treated with 10 nM duocarmycin A at 37‡C
for the indicated times. After the treatment, samples were assessed
for YVAD- or DEVD-speci¢c protease activation. Reactions were
initiated by addition of 20 WM YVAD- or DEVD-AFC to the cell
extract. Product formation (protease activity) was monitored by
measuring the £uorescence (excitation at 400 nm, emission at 505
nm). a, Activity of caspase-3 in HL-60; b, activity of caspase-3 in
HP100; E, activity of caspase-1 in HL-60. Results are means þ S.D.
of values obtained from four independent experiments. Asterisks in-
dicate signi¢cant di¡erences between HL-60 cells and HP100 cells
by t-test (**P6 0.01, *P6 0.05).
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